drug value

Market Access

The journey to global market access for innovative therapies is fraught with challenges that vary significantly across the world.

Views & Analysis

Addressing the data and evidence gap in the early stages of asset development.

News

Three more biotechs have revealed their intentions to list on Nasdaq - BlossomHill, VogenX, and Latigo - as 2026 heads for a record IPO haul.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.